In the original version of this article the author name Gerardo Di Scala was originally presented incorrectly as ‘Di Scala Gerardo’; this has been corrected in this article.
Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4) / Vitale A.; Emmi G.; Lopalco G.; Fabiani C.; Gentileschi S.; Silvestri E.; Di Scala G.; Iannone F.; Frediani B.; Galeazzi M.; Lapadula G.; Rigante D.; Cantarini L.. - In: CLINICAL RHEUMATOLOGY. - ISSN 0770-3198. - ELETTRONICO. - 38:(2019), pp. 267-267. [10.1007/s10067-018-4302-0]
Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4)
Emmi G.;Silvestri E.;Di Scala G.;
2019
Abstract
In the original version of this article the author name Gerardo Di Scala was originally presented incorrectly as ‘Di Scala Gerardo’; this has been corrected in this article.I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.